Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

June 30, 2000

Study Completion Date

April 30, 2006

Conditions
Sarcoma
Interventions
BIOLOGICAL

filgrastim

DRUG

doxorubicin hydrochloride

DRUG

ifosfamide

DRUG

mesna

DRUG

vincristine sulfate

PROCEDURE

conventional surgery

RADIATION

brachytherapy

RADIATION

low-LET cobalt-60 gamma ray therapy

RADIATION

low-LET electron therapy

RADIATION

low-LET photon therapy

Trial Locations (9)

1211

Clinique de Pediatrie, Geneva

22908

Cancer Center, University of Virginia HSC, Charlottesville

67214

Via Christi Regional Medical Center, Wichita

70112

MBCCOP - LSU Medical Center, New Orleans

75230

Medical City Dallas Hospital, Dallas

38105-2794

Saint Jude Children's Research Hospital, Memphis

78236-5300

San Antonio Military Pediatric Cancer and Blood Disorders Center, Lackland Air Force Base

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

00936-5067

University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00002804 - Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter